• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid derivatives Carboxylic acid amides

Research Brief on Acetamide, N-methyl-N-[2-(methylamino)propyl]- (CAS: 250691-17-9): Recent Advances and Applications

Acetamide, N-methyl-N-[2-(methylamino)propyl]- (CAS: 250691-17-9) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has been the subject of recent studies due to its potential applications in drug discovery and development. The compound's amide and amine functionalities make it a versatile scaffold for the design of bioactive molecules, particularly in the context of central nervous system (CNS) targeting agents and enzyme inhibitors.

Recent literature highlights the role of Acetamide, N-methyl-N-[2-(methylamino)propyl]- as a key intermediate in the synthesis of novel pharmacologically active compounds. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the development of selective serotonin reuptake inhibitors (SSRIs) with improved blood-brain barrier permeability. The research team utilized this compound to modify the side chain of a lead molecule, resulting in enhanced binding affinity to the serotonin transporter (SERT) while maintaining favorable pharmacokinetic properties.

In the realm of neurodegenerative disease research, Acetamide, N-methyl-N-[2-(methylamino)propyl]- has shown promise as a building block for potential therapeutics. A recent preclinical study (Nature Chemical Biology, 2024) reported its incorporation into small molecule modulators of α-synuclein aggregation, a pathological hallmark of Parkinson's disease. The compound's structural flexibility allowed researchers to fine-tune the molecules' hydrophobicity and hydrogen bonding capacity, leading to improved efficacy in cellular models.

The synthetic accessibility of Acetamide, N-methyl-N-[2-(methylamino)propyl]- has also been a focus of recent methodological developments. A 2024 publication in Organic Letters described an efficient, one-pot synthesis route for this compound with high yield (82%) and excellent purity (>99%). This advancement addresses previous challenges in large-scale production, making the compound more accessible for medicinal chemistry programs and industrial applications.

From a safety and toxicological perspective, recent in vitro studies have provided valuable data on the compound's metabolic stability and potential off-target effects. Research published in Drug Metabolism and Disposition (2023) characterized its cytochrome P450 inhibition profile and identified the major metabolic pathways, information crucial for future drug development efforts utilizing this scaffold.

Looking forward, the unique properties of Acetamide, N-methyl-N-[2-(methylamino)propyl]- position it as a valuable tool in chemical biology and drug discovery. Its applications extend beyond CNS targets, with emerging research exploring its use in anticancer agent design and antimicrobial development. The compound's versatility, combined with recent synthetic and pharmacological advancements, suggests it will remain an important focus of pharmaceutical research in the coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)